Merck KGaA (OTCMKTS:MKGAF) Stock Price Up 10.2% – What’s Next?

Merck KGaA (OTCMKTS:MKGAFGet Free Report) shares shot up 10.2% on Tuesday . The company traded as high as $142.5530 and last traded at $142.5530. 192 shares traded hands during trading, a decline of 67% from the average session volume of 583 shares. The stock had previously closed at $129.3370.

Merck KGaA Price Performance

The stock has a 50 day moving average price of $137.77 and a two-hundred day moving average price of $139.62. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The company has a market capitalization of $18.42 billion, a PE ratio of 21.76 and a beta of 0.96.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Recommended Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.